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ABSTRACT 
Surviving motoneurons undergo dendritic atrophy after spinal cord injury (SCI), suggesting an 
important therapeutic target for neuroprotective strategies to improve recovery of function after 
SCI.  Our previous studies showed that phospholipase A2 (PLA2) may play an important role in 
the pathogenesis of SCI.  In the present study, we investigated whether blocking cPLA2 
pharmacologically with arachidonyl trifluoromethyl ketone (ATK) or genetically using cPLA2 
knockout (KO) mice attenuates motoneuron atrophy following SCI.  C57BL/6 mice received 
either sham or contusive SCI at the T10 level.  At 30 min after SCI, mice were treated with ATK 
or vehicle.  Four weeks later, motoneurons innervating the vastus lateralis muscle of the 
quadriceps were labeled with cholera toxin-conjugated horseradish peroxidase, and dendritic 
arbors were reconstructed in three dimensions.  Soma volume, motoneuron number, lesion 
volume, and tissue sparing were also assessed, as were muscle weight, fiber cross-sectional area, 
and motor endplate size and density.  ATK administration reduced percent lesion volume and 
increased percent volume of spared white matter compared to the vehicle-treated control 
animals.  SCI with or without ATK treatment had no effect on the number or soma volume of 
quadriceps motoneurons. However, SCI resulted in a decrease in dendritic length of quadriceps 
motoneurons in untreated animals, and this decrease was completely prevented by treatment with 
ATK. Similarly, the vastus lateralis muscle weights of untreated SCI animals were smaller than 
those of sham-surgery controls, and these reductions were prevented by ATK treatment. No 
effects on fiber cross-sectional areas, motor endplate area or density were observed across 
treatment groups. Remarkably, genetically deleting cPLA2 in cPLA2 KO mice attenuated 
dendritic atrophy after SCI. These findings suggest that after SCI, cord tissue damage and 
regressive changes in motoneuron and muscle morphology can be reduced by inhibition of 
cPLA2, further supporting a role for cPLA2 as a neurotherapeutic target for SCI treatment. 
 
Key words: cPLA2; neuroprotection; morphology; dendrites; atrophy. 
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Abbreviations: SCI, spinal cord injury; PLA2, phospholipase A2; ATK, arachidonyl 
trifluoromethyl ketone; sPLA2, secretory PLA2; cPLA2, cytosolic PLA2; iPLA2, Ca
2+
-
independent PLA2; PFA, platelet activating factor; BHRP, horseradish peroxidase conjugated to 
the cholera toxin B subunit; ANOVA, analysis of variance 
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Introduction 
Traumatic spinal cord injuries are prevalent in the United States, where more than 11,000 people 
per year survive a spinal cord injury (SCI).  Of these, around 45% suffer from spinal motoneuron 
lesions, and this number rises to around 95% for those with lumbar or sacral injuries 
1
. The 
pathophysiology of SCI involves both immediate and secondary effects.  After the initial trauma, 
a protracted period of progressive damage occurs, causing spreading of the lesion and further 
segmental destruction.  A variety of mechanisms contribute to this progressive secondary injury, 
including excitotoxicity 
2
, free radical generation 
3
, and inflammation 
4
, resulting in the death of 
motoneurons, interneurons, and glial cells at the lesion site.  Caudal to the lesion, surviving 
motoneurons respond to injury with marked dendritic retraction 
5
.  This secondary dendritic 
atrophy is likely responsible for at least some of the movement deficits and reduces the 
excitability of the remaining motoneurons 
6
.  The target musculature of these motoneurons is 
also affected, with reductions in weight and fiber cross-sectional fiber diameter 
5
. 
Given that we currently lack the technology to replace dead motoneurons, developing the 
ability to protect motoneurons from injury-induced cell death and/or surviving motoneurons 
from secondary atrophy is an important goal.  Our previous studies suggest that activation of 
phospholipase A2 (PLA2) may play an important role in mediating the secondary effects of SCI 
7, 
8
.  The hydrolysis of membrane phospholipids by PLA2 is a rate-limiting step for generation of 
pro-inflammatory mediators such as eicosanoids and platelet activating factor (PAF) 
9-11
.  The 
eicosanoids and PAF are well-known mediators of inflammation and tissue injury and have been 
implicated in pathological states of numerous acute and chronic neurological disorders 
9, 10, 12
.  
SCI significantly increased total PLA2 activation and expression of cPLA2 
8
.  Furthermore, 
expression of phosphorylated cPLA2, a marker for cPLA2 activation, was increased post-injury in 
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injured axons, glial cells, and neurons 
13
. Administration of exogenous PLA2 or melittin, a potent 
activator of endogenous PLA2, resulted in cultured spinal neuronal death in a dose-dependent 
manner 
8
.  Importantly, such PLA2- or melittin-mediated neuronal death could be significantly 
reversed by inhibiting PLA2 
7, 8
, and inhibition of PLA2 improved behavioral recovery after SCI 
in mice 
13
.  Thus, blocking PLA2 activation may represent a novel strategy to reduce multiple 
damaging processes in the course of secondary SCI that leads to motoneuron atrophy. 
To date, more than 27 isoforms of PLA2 have been found in the mammalian system which 
can be classified into three major categories: secretory PLA2 (sPLA2), cytosolic PLA2 (cPLA2) 
and Ca
2+
-independent PLA2 (iPLA2) 
11, 14
. Of these, cPLA2 is the most important PLA2 isozyme, 
and has been implicated as an effector in receptor-mediated release of arachidonic acid (AA) and 
exhibits strong preference for deacylation of AA over other fatty acids 
9, 15
. Because cPLA2 
activation mediates Sema3A-induced growth cone collapse 
16, 17
, it is possible that cPLA2 
activation is involved in dendritic atrophy after SCI. However, no studies to date have examined 
whether cPLA2 has a role in motoneuron atrophy. In this study, we investigated the effects of 
cPLA2 inhibition on spinal motoneurons and their target musculature after SCI. 
 
Materials and methods 
Female C57BL/6 mice (12 weeks) were purchased from Jackson Laboratories (Bar Harbor, 
ME).  Female cPLA2
-/-
 mice and wild-type (WT) littermates (12 weeks) generated from 
heterozygous breeding pairs at Indiana University School of Medicine Laboratory Animal 
Resource Center were used in this study. The mice were maintained on a 12:12 light/dark cycle 
with food and water freely available. A total of 38 animals were used for the study and they were 
divided into 5 groups: sham-operated (n = 6), SCI (n = 8), SCI+ATK (n =8), wild-type SCI (n 
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=8) and cPLA2 KO SCI (n = 8). All surgical interventions and postoperative animal care were 
performed in accordance with the Guide for the Care and Use of Laboratory Animals (National 
Research Council) and were approved by the Indiana University Institutional Animal Care and 
Use Committee. 
 
Spinal cord contusion and treatment  
Mice were anesthetized by an intraperitoneal injection of 2.5% Avertin (2,2,2-tribromo-
ethanol, 0.15ml/10g body weight, Sigma, St Louis, MO).  A T10 laminectomy was performed to 
expose the underlying thoracic spinal cord segment(s), and animals received a (60 kDyne) 
contusion injury using an Infinity Horizon (IH) impactor.  Spinal cord injury at the T10 vertebra 
(T12-13 spinal cord) 
18
 was intended to preserve central pattern generators at L1-2 required for 
locomotor function, and the relevant motoneurons for our analysis.  Sham control animals 
received laminectomy only. After injury, the muscles and skin were closed in layers, and animals 
were placed in a temperature- and humidity-controlled chamber overnight. Manual bladder 
expression was carried out at least 3 times daily until reflex bladder emptying was established. 
Following contusion injury, mice were treated with a potent and selective slow binding 
inhibitor of cPLA2, arachidonyl trifluoromethyl ketone (ATK) 
19
.  ATK (Cayman Chemicals, 
Ann Arbor MI) was injected intravenously (50 μl of 4 mM) at 30 min after injury; mice received 
additional ATK injections administered intraperitoneally (200 μl of 4 mM) on every other day up 
to 2 weeks post-injury; another group of SCI animals received vehicle injections.  The dose and 
treatment regimen were selected based on our previous publication
13
 and a previous published 
report
20
. Animals were allowed to survive for 4 weeks following SCI, a length of time sufficient 
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to observe induced effects on motoneuron morphology 
6, 21-23
.  An additional group of age-
matched, sham-injured (laminectomy only) females served as normal controls. 
 
Injection of horseradish peroxidase conjugated to cholera toxin B subunit 
Four weeks after injury, animals were re-anesthetized, and the left vastus lateralis muscle of 
the quadriceps was exposed and injected with horseradish peroxidase conjugated to the cholera 
toxin B subunit (BHRP; 0.5 µl, 0.2%; List Biological, Inc.).  BHRP labeling permits population-
level quantitative analysis of motoneuron somal and dendritic morphologies 
24, 25
.  Forty-eight 
hours after BHRP injection, a period that ensures optimal labeling of motoneurons 
24, 25
, animals 
were weighed and received a lethal dose of Nembutal (60 mg/kg, i.p.), and were then perfused 
intracardially with saline followed by cold fixative (1% paraformaldehyde/1.25% 
glutaraldehyde). 
 
Tissue processing, histology, and lesion assessments 
A 12 mm thoracic spinal cord segment including the lesion was removed, postfixed overnight 
in the same fixative as used for perfusion, and transferred to sucrose phosphate buffer (30% w/v, 
pH 7.4).  Thoracic segments were then embedded in gelatin, frozen, and sectioned transversely at 
40 µm; alternate sections were collected into two series, and mounted on gelatin-coated slides.  
One series was stained with cresyl violet and eosin for assessing lesion and spared tissue volume.  
The cross-sectional areas of lesion or spared white and gray matter for each animal were 
measured in sections located 240 µm apart and spanning the entire rostrocaudal extent of the 
lesion using a video-based morphometry system (Stereo Investigator; MBF Bioscience, 
Williston, VT) at a final magnification of 202X.  An unbiased estimation of the percentage of 
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spared tissue was calculated using the Cavalieri method 
26
.  The total volume of spared white and 
gray matter was calculated by summing their individual subvolumes 
27
.  Individual subvolumes 
of spared tissue were calculated by multiplying the cross-sectional area A x d, where d represents 
the distance between sections (240 µm).  The percent total volume of spared white and gray 
matter was calculated by dividing the total volume of spared white and gray matter by the total 
tissue volume of the corresponding region (x100), respectively.  Estimation of total and percent 
total lesion volume was determined using identical procedures.  The remaining series of thoracic 
sections were stained for myelin using Luxol fast blue as described previously 
7
.  The lesion area 
and total spinal cord area were outlined from a section through the lesion epicenter and sections 
located either 240 µm rostral or caudal to the epicenter using Stereo Investigator.  The percent 
lesion area was determined by dividing the lesion area by the spinal cord area from the same 
section. 
 
Motoneuron morphology and quantification 
The vastus lateralis muscle is innervated by motoneurons located in column 3 of the lateral 
motor column in the L2 spinal segment 
28-30
.  Following perfusion, the lumbar portion of the 
spinal cord of each animal was removed, postfixed for 5 hours in the same fixative as used for 
perfusion, and then transferred to sucrose phosphate buffer (10% w/v, pH 7.4) overnight for 
cryoprotection.  Spinal cords were then embedded in gelatin, frozen, and sectioned transversely 
at 40 µm; all sections were collected into 4 alternate series.  One series was stained with thionin 
for use in cell counts.  For visualization of BHRP, the 3 remaining series were immediately 
reacted using a modified tetramethyl benzidine protocol 
5
, mounted on gelatin-coated slides, and 
counterstained with thionin. 
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Motoneurons innervating the quadriceps muscles do not form a discrete nucleus, but instead 
are contained within the large continuous populations of motoneurons located within the lateral 
motor column.  Thus, to identify the appropriate area within the lateral motor column for 
motoneuron counts in the unreacted series, we used a method similar to that of Little et al. 
6
.  
Briefly, for each animal the range of sections in which motoneurons labeled with BHRP after 
injection into the vastus lateralis muscle were present in the reacted series was identified, and 
then motoneuron counts were performed in the appropriate matching sections in the unreacted 
series.  For each animal, estimates of the total number of motoneurons in the left and right lateral 
motor columns were obtained using the optical disector method previously described 
6
.  Counts 
were made at 937.5X under brightfield illumination.  Motoneurons are easily recognizable as 
large, darkly staining, multipolar cells.  A counting frame (110 m X 80 m) was moved 
systematically throughout an area of each ventral horn (approximately 350 m X 350 m, 
defined by the actual distribution of BHRP-labeled somata from all of the animals used in the 
study) in each section within the identified range.  Only motoneurons in which there was a clear 
nucleus and nucleolus were counted, provided they did not contact the forbidden lines of the 
counting frame; motoneuron nucleoli were counted as they appeared while focusing through the 
z axis, and nucleoli in the first focal plane (i.e., "tops") were excluded to avoid double counting. 
Motoneuron counts were derived from a mean of 5.33 sections spaced 480 µm apart and 
distributed uniformly through the entire rostrocaudal extent of the quadriceps motoneuron pool 
range.  Cell counts for each animal were corrected for the proportion of sections sampled. 
Using similar methods, the number of BHRP-labeled motoneurons was assessed in all 
sections of the reacted series through the entire rostrocaudal extent of their distribution for all 
animals.  Counts of labeled quadriceps motoneurons were made under brightfield illumination, 
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where somata could be visualized and cytoplasmic inclusion of BHRP reaction product 
confirmed. 
 
Soma volume  
The volume of quadriceps motoneuron somata was assessed in at least one set of alternate 
sections (160 µm apart) using the Nucleator method 
31
. A set of 4 rays emanating from a point 
randomly chosen within each BHRP-labeled motoneuron soma was drawn and oriented 
randomly.  Soma volumes of an average of 28.1 motoneurons were measured for each animal 
using Stereo Investigator at a final magnification of 780X.  Soma volumes within each animal 
were then averaged for statistical analysis. 
 
Dendritic length 
For each animal, dendritic lengths in a single representative set of alternate sections were 
measured under darkfield illumination.  Beginning with the first section in which BHRP-labeled 
fibers were present, labeling through the entire rostrocaudal extent of the quadriceps motoneuron 
dendritic field was assessed in every third section (480 µm apart) in three dimensions using a 
computer-based morphometry system (Neurolucida; MBF Bioscience, Williston, VT) at a final 
magnification of 250X.  Average dendritic length per labeled motoneuron was estimated by 
summing the measured dendritic lengths of the series of sections, multiplying by three to correct 
for sampling, then dividing by the total number of labeled motoneurons in that series.  This 
method does not attempt to assess the actual total dendritic length of labeled motoneurons 
32
, but 
has been shown to be a sensitive and reliable indicator of changes in dendritic morphology in 
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normal development 
24, 33, 34
, after changes in dendritic interactions 
33
 and afferent input 
35-37
, and 
after injury 
6, 21-23, 38
. 
 
Dendritic distribution 
To assess potential redistributions of dendrites across treatment groups, for each animal the 
composite dendritic arbor created in the length analysis was divided using a set of axes oriented 
radially around the center of the collective labeled somata.  These axes divided the spinal cord 
into 12 bins of 30° each.  The portion of each animal’s dendritic arbor per labeled motoneuron 
contained within each location was then determined.  This method provides a sensitive measure 
of dendritic redistribution in response to changes in dendritic interactions 
33
 and afferent input 
35, 
36
. 
 
Dendritic extent 
The comparability of BHRP labeling across groups was assessed by quantifying both the 
rostrocaudal and the radial extent of quadriceps motoneuron dendritic arbors.  The rostrocaudal 
extent of the dendritic arbor was determined by recording the rostrocaudal distance spanned by 
quadriceps motoneuron dendrites for each animal.  The maximal radial extent of the arbor in the 
transverse plane was also measured for each animal, using a set of axes oriented radially around 
the center of the collective labeled somata.  These axes divided the spinal cord into 12 bins of 
30° each.  For each bin, the linear distance between the center of the quadriceps motor pool and 
the most distal BHRP-filled process was measured.  Radial dendritic extent is independent of 
overall dendritic length and reflects the maximal linear distance (in the transverse plane) of 
BHRP transport to the most distal dendritic processes. 
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Muscle fiber and motor endplate morphology 
The right vastus lateralis muscles were removed immediately after perfusion and weighed.  
Muscles were then postfixed overnight in the same fixative as used for perfusion, and then 
transferred to sucrose phosphate buffer (10% w/v, pH 7.4).  Muscles were then rinsed in distilled 
water, blocked into proximal and distal segments, and flash-frozen in 2-methylbutane.  Muscle 
segments were then sectioned (45 µm) either transversely (for examination of muscle fiber cross-
sectional area) or longitudinally (for examination of motor endplate area and density) on a 
cryostat at -20° C and thaw-mounted onto glass slides.  Muscle fiber cross-sectional area was 
assessed after staining with Milligan’s trichrome stain.  Motor endplate size and density were 
assessed after staining for acetylcholinesterase using the Roots-Karnovsky method 
39
.  Cross-
sectional muscle fiber area and motor endplate size were measured under brightfield illumination 
using Stereo Investigator.  To obtain accurate measures of motor endplate size, only en face 
profiles were traced.  An average of 32.5 muscle fibers and 30.0 endplates were measured for 
each animal at a final magnification of 510X.  The number of motor endplates per muscle fiber 
was estimated by counting the number of muscle fibers and endplates in a grid (1 mm X 1 mm), 
randomly placed on the muscle section (1 sample field per section, 5 muscle sections per 
animal).  An average of 139.8 muscle fibers per animal was examined.  Fiber and endplate areas 
within each animal were then averaged for statistical analysis. 
 
Statistical analysis 
All data are presented as mean ± SEM and were analyzed by t-tests or analyses of variance 
(one way, two way, or repeated measures as appropriate) followed by post hoc analyses using 
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Fisher’s least significant difference (LSD).  Digital light micrographs were obtained using an 
MDS 290 digital camera system (Eastman Kodak Company, Rochester, NY).  Brightness and 
contrast of these images were adjusted in Adobe Photoshop (Adobe Systems, San Jose, CA). 
 
Results 
 
Lesion volume and white matter sparing 
Contusive SCI resulted in large lesion with thin rims of spared tissue (Fig. 1A-B).  In both 
SCI groups, faint staining with Luxol Fast Blue indicated that contusion injury resulted in areas 
of demyelination immediately surrounding the lesion.  Measurements of the percent lesion area 
in Luxol Fast Blue-stained sections indicated that treatment with ATK had no effect on the 
percent lesion area at the injury epicenter, with the lesion occupying an average of 81.68% of the 
total cord area [t(12) = -0.652, ns; Fig. 1C].  In contrast, lesion volumes in vehicle-treated 
animals (1.38 ± 0.22 mm
3
; Mean ± SEM) were significantly larger than those of ATK-treated 
animals [0.86 ± 0.08 mm
3
; F(1,12) = 6.25;  p<0.03; Fig. 1D].  To correct for changes in spinal cord 
contour after spinal cord contusion, the percent lesion volume was also determined.  As for total 
lesion volume, ATK treatment had a significant effect on percent lesion volume (SCI+vehicle, 
13.48 ± 2.52%; SCI+ATK, 8.20 ± 1.07%) and percent volume of spared white matter 
(SCI+vehicle, 50.70 ± 1.22%; SCI+ATK, 54.48 ± 0.86%); percent volume of spared gray matter 
[SCI+vehicle, 35.81 ± 1.43%; SCI+ATK, 37.32 ± 0.65%; F(1, 24) = 4.31, p<0.03; Fig. 1E].  
Importantly, despite the large size of the lesions, they did not extend into the L2 level, and thus 
did not compromise the quadriceps motoneuron populations directly. 
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Motoneuron counts 
In sham animals, the number of motoneurons within the identified quadriceps range averaged 
727.50 (± 100.09).  Contusive SCI with or without ATK treatment had no effect on the number 
of quadriceps motoneurons [SCI+vehicle, 668.00 ± 72.11; SCI+ATK, 708.00 ± 108.43; [F(2, 19) = 
0.09, ns]. 
 
Motoneuron morphometry 
Injection of BHRP into the left vastus lateralis successfully labeled ipsilateral quadriceps 
motoneurons in all groups (Fig. 2).  Labeled motoneurons were located in the lateral motor 
column in the L2 spinal segment (Nicolopoulos-Stournaras and Iles, 1983, Little et al., 2009).  
Dendritic arbors were strictly unilateral, with extensive ramification along the ventrolateral edges 
of the gray matter and in the lateral funiculus, as well as throughout the ventral horn.  An average 
of 73.92 ± 6.60 motoneurons per animal were labeled with BHRP, and did not differ by group 
[F(2,18) = 0.24, ns]. 
 
Soma volume 
In sham animals, quadriceps motoneuron somata were typical in size (12,539.46 ± 644.53 
μm3, and did not differ from those of SCI+vehicle (12,561.79 ± 378.75 μm3) or SCI+ATK 
animals [11,926.33 ± 690.53 μm3; F(2,19) = 0.35, ns]. 
 
Dendritic length   
Following contusion injury, quadriceps motoneurons underwent marked dendritic atrophy.  
Dendritic length decreased by 28.3% [2870.71 ± 215.17 µm in SCI+vehicle animals compared to 
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4002.23 ± 193.64 µm for sham animals, LSD, p < .05; overall test for the effect of group on 
arbor per cell F(2,18) = 3.68, p < .05; Fig. 3A].  However, treatment with ATK attenuated SCI-
induced dendritic atrophy: dendritic lengths in SCI+ATK animals (4210.34 ± 550.30 μm) were 
46.7% longer than those of SCI+vehicle animals (LSD p < .03), and did not differ from those of 
sham animals (LSD, ns) [Fig. 3A]. 
Dendritic length per bin was nonuniform across radial bins, and a repeated-measures 
ANOVA revealed a significant effect of radial location [F(11,198) = 21.76, p < .0001; Fig. 3B].  
Consistent with the results of the arbor per cell analysis, there was also a significant effect of 
group [F(2,198) = 3.58, p < .05].  Reductions in dendritic length occurred throughout the radial 
distribution in SCI+vehicle animals compared to sham animals [an average of 23.6%, 0° to 300°; 
F(1,132) = 15.64, p < .01], with the largest reduction occurring ventromedially (300° to 360°; 
38.9%); however, the group x location interaction did not reach significance [F(11,132) = 1.67, p = 
.086].  Treatment with ATK attenuated SCI-induced reductions in dendritic length per bin 
throughout the radial distribution and there were no group differences [F(1,143) = 0.14, ns] and no 
group x location interaction [F(11,143) = 0.69, ns] between SCI+ATK animals and sham animals.  
Dendritic lengths per bin in SCI+ATK animals were longer than those of SCI+vehicle animals 
throughout the radial distribution [F(1,121) = 4.44, p < .05]; there was no group x location 
interaction [F(11,121) = 0.70, ns]. 
To definitively determine the role of cPLA2 in dendritic atrophy after SCI, we used cPLA2
-/- 
mice and compared them with WT littermates (cPLA2
+/+
). Dendritic length decreased by 24.61% 
(3017.13 ± 361.67 μm in WT SCI animals compared to 4002.23 ± 193.64 μm in sham animals. 
cPLA2 deletion attenuated SCI-induced dendritic atrophy: dendritic lengths in cPLA2 KO mice 
were 3766.44 ± 325.74 μm, which were 24.84% longer than those of WT animals. These 
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differences in dendritic lengths across groups approached statistical significance [F(2,21)= 2.89, 
p = .077; Fig. 3D]. 
Dendritic length per bin was non-uniform across radial bins, and a repeated measures 
ANOVA revealed a significant effect of radial location [F(11,231) = 27.49, p < .05; Fig. 3E]. 
Consistent with the results of the arbor per cell analysis, the effect of group was significant 
[F(2,231) = 4.95, p < .05], with reductions in dendritic length occurring throughout the radial 
distribution in WT SCI animals compared to sham animals (an average of 22.15%); there was no 
significant group x location interaction [F(22,231) = 1.07, ns]. cPLA2 deletion attenuated SCI-
induced reductions in dendritic length per bin, and there were no group differences [F(1,154) = 
1.32, ns] and no group x location interaction [F(1,154) = .42, ns] between SCI cPLA2 KO 
animals and sham animals. Dendritic lengths per bin in cPLA2 KO animals were longer than 
those of WT animals after SCI throughout the radial distribution, an average of 35.53%, but this 
difference failed to reach statistical significance [F(1,154)= 3.30, p = .09]. There was no group x 
location interaction [F(11,154) = 1.03, ns]. 
 
Dendritic extent  
Consistent with the nonuniform dendritic distribution of quadriceps motoneurons apparent in 
Figure 2, radial dendritic extent differed across bins (Fig. 3C), and repeated-measures ANOVA 
revealed a significant effect of location [F(11,198) = 40.39, p < .0001].  However, radial dendritic 
extent did not differ across groups [F(2,198) = 3.26, ns].  Rostrocaudal dendritic extent also did not 
differ across groups [F(2,18) = 1.11, ns], spanning 3220.00 ± 231.15 µm in sham animals, 2853.33 
± 186.67 µm in SCI+vehicle animals, and 2811.43 ± 223.17 µm in SCI+ATK animals. In cPLA2 
KO mice, consistent with the non-uniform dendritic distribution of quadriceps motoneurons, 
radial dendritic extent differed across bins, and repeated-measures ANOVA revealed a 
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significant effect of location [F(11,231) = 62.26, p < .05; Fig. 3F]. However, radial dendritic extent 
did not differ across groups [F(2,231) = 3.14, ns; Fig. 3F]. Rostrocaudal dendritic extent also did 
not differ across groups [F(2,21) = 1.97, ns], spanning 3220.00 ± 231.15 μm in sham animals, 
2680.00 ± 156.39 μm in SCI WT animals, and 2740.00 ± 235.07 μm in  cPLA2 KO SCI animals. 
 
 
Muscle weight and fiber size 
Overall body weight was not affected: animals weighed an average of 19.96 ± 0.38 g at the 
end of treatment, and this did not differ between groups [F(2,19) = 2.44, ns].  However, muscle 
weights were affected by contusion injury (Fig. 4B).  Weights of the vastus lateralis muscles 
decreased by 28.2% (0.05 ± 0.003 g in SCI+vehicle animals compared to 0.071 ± 0.002 g for 
sham animals, LSD, p < .0001; overall test for the effect of group on muscle weight F(2,19) = 
17.81, p < .0001].  However, treatment with ATK attenuated SCI-induced muscle atrophy: 
weights of the vastus lateralis muscles in SCI+ATK animals (0.067 ± 0.002 g) were 31.4% larger 
than those of SCI+vehicle animals (LSD p < .0001), and did not differ from those of sham 
animals (LSD, ns). 
Muscle fiber size was also affected by contusion injury (Fig. 4C).  Cross-sectional area of 
vastus lateralis muscle fibers decreased by 26.6% (454.53 ± 51.63 µm
2
 in SCI+vehicle animals 
compared to 619.28 ± 47.72 µm
2
 for sham animals, LSD, p < .05; overall test for the effect of 
group on muscle fiber area [F(2,18) = 5.56, p < .05].  However, treatment with ATK failed to 
attenuate SCI-induced muscle fiber size: cross-sectional areas of vastus lateralis muscle fibers in 
SCI+ATK animals (475.50 ± 10.38 µm
2
) were not different from those of SCI+vehicle animals 
(LSD, ns), and were 23.2% smaller than those of sham animals (LSD, p < .05). 
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Motor endplate size and density 
Contusion injury with or without ATK treatment had no significant effects on motor endplate 
size.  In sham animals, motor endplate areas were typical in size (1147.92 ± 36.71 μm2), and did 
not differ from those of SCI+vehicle (1092.02 ± 50.40 μm2) or SCI+ATK animals [1083.69 ± 
36.57 μm2; F(2,19) = 0.80, ns; Fig. 5B]. Similarly, the density of motor endplates did not differ 
across groups [sham animals, 0.55 ± 0.04 endplates per fiber; SCI+vehicle animals, 0.60 ± 0.05 
endplates per fiber, SCI+ATK animals 0.51 ± 0.04 endplates per fiber; F(2,18) = 1.44, ns; Fig. 5C]. 
 
Discussion 
In this study, we found that ATK treatment can completely prevent pronounced dendritic 
atrophy in spinal motoneurons caudal to a contusive SCI, indicating a protective role of cPLA2 
inhibition on prevention of motoneuron dendritic degeneration after SCI. Genetic deletion of 
cPLA2 significantly reduced dendritic atrophy after SCI.  It should be noted that after SCI, 
motoneurons caudal to the injury are morphologically intact and are not directly traumatized by 
the injury. Inhibition of cPLA2 also prevented decreases in the weights of the target musculature.  
To our knowledge, this is the first study demonstrating a neuroprotective effect of cPLA2 
inhibition on motoneuron dendritic degenerative change and muscle morphology following SCI. 
Such injury induced secondary effect on motoneurons and associated musculature remote to the 
injury itself may provide new targets for therapeutical interventions aimed at enhancing recovery 
of functional after SCI.   
 
 cPLA2 inhibition as a neuroprotective strategy 
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Mouse SCI models are being increasingly used because transgenic and knockout mice are 
available for the study of cellular mechanisms.  Certain mouse strains, such as C57BL/6, 129/Sv, 
and B10.rIII, have a naturally occurring null mutation of the major form of sPLA2 
40
. Therefore, 
C57BL/6 mice in this study were deficient in sPLA2. ATK is a potent and selective inhibitor of 
cPLA2. This inhibitor shows slow tight binding to cPLA2 in the presence of Ca
2+
 and forms a 
covalent bond with a serine residue in the active site of the enzyme 
19, 41
.  This inhibitor is about 
500-fold more potent at inhibiting cPLA2 than sPLA2 
19
 and may also be a weak inhibitor of 
iPLA2 
42-44
. 
Following contusion, the focal injuries delivered to the spinal cord developed into large 
lesions that spanned multiple thoracic spinal segments. Such lesions were significantly reduced 
by ATK treatment.  Notably, the cPLA2 inhibitor was administered after trauma, modeling a 
clinically relevant situation.  These findings are in agreement with our previous studies that 
inhibition of PLA2 reduced tissue damage and increased spared white matter after SCI 
7, 13
.  
Several other studies also reported a detrimental effect of cPLA2 in other CNS diseases such as 
ischemia 
45, 46
, experimental autoimmune encephalomyelitis 
20, 47
 and Alzheimer’s disease 48. 
Our previous studies showed that SCI significantly induced cPLA2 activation, which was 
observed as early as 8 h post-injury and peaked at 7 d post-injury. The activated cPLA2 was 
mainly localized in neurons and oligodendrocytes. It has also been shown that arachidonic acid 
(AA) and eicosanoids, downstream metabolites of cPLA2, increased as early as 30 min after SCI 
49, 50
. The increased eicosanoids were persistent for at least 3 d (the longest time point studied) 
after SCI 
51
. In addition, concentrations of free fatty acid quickly increased after SCI, peaked at 3 
d, and remained significantly high at 7 d after SCI 
52
. Since the induction profiles of these PLA2 
metabolites are similar to that of cPLA2 after SCI, a prolonged effect of cPLA2 after SCI exists, 
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suggesting that there might be a unique “therapeutic window” for intervention. Although cPLA2 
inhibitor in the present study was administered for two weeks after trauma, the optimal 
therapeutic time window for such treatment remains to be determined. 
 
Changes in motoneuron morphology are not direct effects of lesion 
Although extensive, spinal lesions did not extend into the lumbar spinal cord, thus sparing 
the gray matter and resident motoneurons. Counts of either Nissl-stained or BHRP-labeled 
motoneurons in SCI animals did not differ from those of sham animals, confirming that 
quadriceps motoneurons were not directly damaged by the initial trauma or secondary 
degeneration occurred at the lesion site.  Similarly, soma size of quadriceps motoneurons was not 
significantly affected by the SCI, further suggesting that the quadriceps motoneurons were not 
directly damaged by the SCI 
5
.  
 
Dendritic atrophy after SCI 
Afferent input to motoneurons is important for the maintenance of dendritic morphology, 
and deafferentation often results in dendritic retraction. Following deafferentation via damage to 
the dorsal horn 
53
, spinal cord hemisection or transection 
35, 54
, or cortical ablation 
55
, spinal 
motoneurons undergo dendritic atrophy. Activity in afferent pathways is an important factor in 
maintaining dendritic morphology. For example, cold block of the spinal cord causes dendritic 
morphological changes to develop within 4 hours 
56
. We have previously reported that following 
SCI and the concomitant loss of descending pathways, spinal motoneurons caudal to the lesion 
undergo marked reductions in their dendritic arbor, especially ventromedially in areas where 
both the reticulospinal and propriospinal projections terminate 
5
.  In the present study, we 
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observed reductions throughout the arbor, but again the reductions were greatest in the 
ventromedial portion of the dendritic distribution. This loss is of particular significance after 
SCI, as descending reticulospinal fibers course through the ventral and lateral funiculi 
57, 58
, and 
disruption of these tracts results in hindlimb motor deficits 
59, 60
. Therefore, it is possible that the 
dendritic atrophy we observed following SCI in untreated animals could reflect deafferentation 
resulting from the loss of descending motor and propriospinal tracts. 
 
Inhibition of cPLA2 attenuates SCI-induced motoneuron dendritic atrophy 
SCI-induced atrophy of quadriceps motoneuron dendrites was attenuated in ATK-treated 
animals. Genetic deletion of cPLA2 also resulted in neuroprotection on dendritic atrophy after 
SCI. However, mechanisms of cPLA2 inhibition-mediated motoneuron atrophy remain unclear. 
One possibility is that ATK treatment could have attenuated dendritic atrophy by increasing the 
number of spared axons that traverse the lesion, which is consistent with the reduction in lesion 
size and corresponding increase in white matter sparing. The other possibility is that cPLA2 may 
have a direct effect on dendrites.  Such a direct effect is supported by other reports that cPLA2 
activation mediates Sema3A-induced growth cone collapse 
16, 17
, suggesting that cPLA2 
activation could be directly involved in dendritic retraction after SCI. The attenuation in 
dendritic atrophy we observed in ATK-treated animals could potentially maintain motor 
activation and account for the protective effects of ATK on locomotor function we have 
observed 
13
.  Such an effect would lead to protection of the target musculature from disuse 
atrophy and could support exercise training effects on locomotor function after SCI 
61, 62
. 
 
Comparability of BHRP labeling 
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We believe that the differences we observed across treatment groups reflect true dendritic 
atrophy in quadriceps motoneurons of untreated SCI animals, which is attenuated by treatment 
with ATK.  However, the possibility that confounding changes arising from SCI could affect 
retrograde transport is an important consideration, as such an artifact could potentially result in 
apparent alterations in dendritic morphology.  However, no differences in either radial or 
rostrocaudal extents of quadriceps motoneuron dendrites in the SCI groups compared to normal 
values were observed.  Therefore, we believe that the dendritic labeling across groups was 
comparable and that the shorter dendritic lengths we observed in the untreated SCI animals 
reflect true dendritic atrophy. 
 
Muscle atrophy after SCI 
The regressive changes we observed in muscle weight and fiber diameter are typical after 
SCI in muscles innervated by motoneurons below the level of the lesion, especially in weight-
bearing muscles such as the quadriceps 
63, 64
. This atrophy can result from either denervation due 
to loss of motoneurons or damage to the ventral roots, or disuse consequent to decreases in 
muscle activation potentially due to the loss of synaptic input to remaining motoneurons 
65
. In 
the current study, the atrophy we observed cannot be ascribed to an effect of denervation, as we 
observed no changes in quadriceps motoneuron number, the number of BHRP-labeled 
quadriceps motoneurons, or the sizes or densities of motor endplates between sham animals and 
untreated SCI animals. Thus, the decreased weight and fiber size we observed most likely reflect 
a disuse atrophy, potentially resulting after damage to descending and propriospinal projections 
and/or the reductions in quadriceps motoneuron dendritic length we observed. Such reductions in 
quadriceps motoneuron dendritic length result in attenuation of motor activation, reducing 
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response amplitudes in the femoral nerve generated by dorsal root afferent stimulation 
6
. 
Alternatively, disuse atrophy may also result from changes in muscle length or loading 
conditions that could decrease protein synthesis and increase protein degradation 
66, 67
. 
 
Protection of muscle with ATK 
In the current study, ATK treatment prevented the atrophy in muscle weight seen after SCI. 
However, there is no significant difference in muscle fiber area between the SCI and SCI + ATK 
treatment group. The reason for the reversal of muscle weight loss without changing of muscle 
fiber size is unclear.  The protection of muscle weight could be the result of a sparing of 
motoneuron function. As described above, ATK treatment can reverse the regressive changes in 
dendritic morphology and motor activation. Thus, the protection from dendritic atrophy with 
ATK treatment after SCI could have spared local spinal circuitry sufficiently to maintain motor 
activation and use leg more for walking, preventing disuse atrophy of the target muscles. 
 
 
Conclusions 
The present results indicate that the regressive changes in motoneuron and muscle 
morphology seen after SCI can be prevented by blocking cPLA2 pharmacologically at 30 min 
post-injury or genetically deleting cPLA2 in mice, potentially providing a mechanism for the 
improved locomotor performance previously observed with cPLA2 inhibitor treatments 
following SCI. Together, these results further support a role for cPLA2 as a therapeutic target for 
treatment of SCI. 
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Figure 1.  Histological and stereological analysis of spinal cord spared tissue and lesion volume 
after contusive spinal cord injury (SCI) with or without arachidonyl trifluoromethyl ketone 
(ATK) treatment. (A) Representative section near the lesion epicenter stained with cresyl violet 
and eosin, showing a large centrally located lesion with areas of spared gray and white matter.  
(B) Neurolucida drawing from the same section showing the lesion area, residual white matter 
(WM), and spared gray matter (GM).  (C) Percentage of lesion area at injury epicenter did not 
differ across injured animals that were either untreated (SCI), or treated with ATK (SCI+ATK).  
However, lesion volumes (D) and percent total volumes (E) of lesion and spared white matters 
differed across groups.  Scale bar =250 µm. 
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Figure 2.  (Left)  Darkfield digital micrographs of transverse hemisections through the lumbar 
spinal cords of a sham animal (top), an injured animal treated with vehicle (spinal cord injury 
[SCI]+vehicle, middle), and an arachidonyl trifluoromethyl ketone (ATK)-treated injured animal 
(SCI+ATK, bottom), after injection of horseradish peroxidase conjugated to the cholera toxin B 
subunit (BHRP) into the left vastus lateralis muscle.  (Right) Computer-generated composites of 
BHRP-labeled somata and processes drawn at 480 μm intervals through the entire rostrocaudal 
extent of the quadriceps motor pool; these composites were selected because they are 
representative of their respective group average dendritic lengths.  Scale bar = 250 µm.   
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Figure 3.  (A)  Dendritic lengths of quadriceps motoneurons after spinal cord injury (SCI).  
Following contusion injury, surviving quadriceps motoneurons lost over 28% of their dendritic 
length.  Treatment with ATK attenuated this dendritic atrophy.  * indicates significantly different 
from sham animals. Inset: Drawing of spinal gray matter divided into radial sectors for measure 
of quadriceps motoneuron dendritic distribution (B and E) and radial dendritic extent (C and F). 
(B)  Length per radial bin of quadriceps dendrites of sham animals (unfilled bars) and injured 
animals that were either untreated (SCI+vehicle, gray bars), or treated with arachidonyl 
trifluoromethyl ketone (ATK) (SCI+ATK, black bars).  For graphic purposes, dendritic length 
measures have been collapsed into 6 bins of 60° each.  Quadriceps motoneuron dendritic arbors 
display a non-uniform distribution, with the majority of the arbor located between 300° and 
120°.  Following contusion injury, surviving quadriceps motoneurons in untreated animals had 
reduced dendritic lengths throughout the radial distribution.  Treatment with ATK attenuated 
these reductions.  * indicates significantly different from sham animals. (C)   Radial extents of 
quadriceps dendrites of sham animals (unfilled bars) and injured animals that were either 
untreated (SCI+vehicle, gray bars), or treated with arachidonyl trifluoromethyl ketone (ATK) 
(SCI+ATK, black bars).  For graphic purposes, dendritic extent measures have been collapsed 
into 6 bins of 60° each.  Following contusion injury, extent measures of surviving quadriceps 
motoneurons in SCI+vehicle and SCI+ATK animals did not differ from those of sham animals.  
(D) Dendritic lengths of quadriceps motoneurons of sham animals and injured animals that were 
either wild type (WT), or cPLA2 KO. Genetic deletion of cPLA2 attenuated SCI-induced 
dendritic atrophy. (E) Length per radial bin of quadriceps dendrites of sham animals (unfilled 
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bars) and injured animals that were either WT (gray bars), or cPLA2 KO mice (black bars). There 
is a significant effect of radial dendritic location. (F) Radial extents of quadriceps dendrites of 
sham animals (unfilled bars) and injured animals that were either WT (gray bars), or cPLA2 KO 
mice (black bars). Radial dendritic extent did not differ across groups. 
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Figure 4.  Histological and morphological analysis of the vastus lateralis muscle after contusive 
spinal cord injury (SCI) with or without treatment. (A) Representative cross section through the 
body of the vastus lateralis muscle from a sham animal stained with Milligan’s trichrome stain.  
Weights (B) and cross-sectional fiber areas (C) of the vastus lateralis muscles in sham animals 
and injured animals that were either untreated (SCI+vehicle), or treated with arachidonyl 
trifluoromethyl ketone (ATK) (SCI+ATK).  Following contusion injury, both the weight and 
fiber size of the vastus lateralis muscle in untreated animals were reduced over 20%.  Treatment 
with ATK attenuated reductions in weight but not fiber area.  Bar heights represent means ± 
SEM.  * indicates significantly different from sham animals.  Scale bar = 100 µm. 
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Figure 5.  Histological and morphological analysis of motor endplate size after contusive spinal 
cord injury (SCI) with or without treatment. (A) Representative longitudinal section through the 
body of the vastus lateralis muscle from a sham animal after staining for acetylcholinesterase.  
SCI had no effect on the motor endplate size (B) or density (C), regardless of treatment.  Bar 
heights represent means ± SEM.  Scale bar = 250 µm. 
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